We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo
Medica 2026
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Goldsite Introduces Automated HbA1c Testing System for High-Volume Laboratories

By LabMedica International staff writers
Posted on 20 Nov 2026

Goldsite Diagnostics introduced the GSH-120 HPLC HbA1c Analyzer at MEDICA 2026, held from November 16–19 at Messe Düsseldorf, Germany. The analyzer was showcased at Hall 1, Stand B56 alongside the GSH-50 and GSH-60 systems in the company’s HPLC HbA1c portfolio. It is designed for high-volume laboratories and delivers up to 120 tests per hour, with a 30-second test cycle.

The GSH-120 uses ion-exchange high-performance liquid chromatography, identified as a JCTLM reference method, to measure HbA1c. It requires 3 µL of whole blood and performs direct cap-piercing without manual uncapping or sample pretreatment. Automated barcode scanning, sample mixing, and simultaneous recognition of primary tubes and dilution cups are intended to reduce hands-on time.


Image: At MEDICA 2026, Goldsite Diagnostics introduced the GSH-120 high-throughput ion-exchange HPLC HbA1c analyzer for high-volume laboratories. (Photo courtesy of Goldsite Diagnostics)
Image: At MEDICA 2026, Goldsite Diagnostics introduced the GSH-120 high-throughput ion-exchange HPLC HbA1c analyzer for high-volume laboratories. (Photo courtesy of Goldsite Diagnostics)

The analyzer includes a 110-sample continuous loading track and a dedicated STAT position, allowing urgent samples to be processed without interrupting routine batch runs. It also features a 10.3-inch tilted touchscreen, bidirectional laboratory information system connectivity, and a built-in thermal printer. For automation, the system supports multi-unit cascading and direct connection to laboratory automation tracks.

Performance specifications include a 2.8%–18.4% measuring range and coefficient of variation precision of 1% or lower. The system reports results in NGSP and IFCC units, as well as HbF and estimated average glucose, in a single 30-second run. Selectable standard and variant/thalassemia modes separate common hemoglobin variants, including HbE, HbD, HbS, and HbC, to reduce variant interference in HbA1c measurement.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Electrolyte Analyzer
BKE-B
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.

Latest Medica 2026 News

Winners Announced of the 18th Healthcare Innovation World Cup at MEDICA 2026
20 Nov 2026  |   Medica 2026

Diazyme Presents Clinical Chemistry Assays for Cancer Biomarkers and Diabetes at MEDICA 2026
20 Nov 2026  |   Medica 2026

Protia Highlights CE-IVDR-Certified Allergy and Autoimmune Diagnostic Tests
20 Nov 2026  |   Medica 2026